1. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest
   Sujin Kang et al, 2015, Cellular Signalling CrossRef
2. Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12
   Zhi Guo et al, 2016, Biomedical Reports CrossRef
3. Crosstalk between oncolytic viruses and autophagy in cancer therapy
   Ke-Tao Jin et al, 2021, Biomedicine & Pharmacotherapy CrossRef
4. An image cytometric technique is a concise method to detect adenoviruses and host cell proteins and to monitor the infection and cellular responses induced
   Takao Morinaga et al, 2017, Virology Journal CrossRef
5. Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
   So Young Kim et al, 2017, Oncotarget CrossRef
6. Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes
   Suguru Yamauchi et al, 2017, BMC Cancer CrossRef
7. Autophagy in Tumor Immunity and Viral-Based Immunotherapeutic Approaches in Cancer
   Ali Zahedi-Amiri et al, 2021, Cells CrossRef
8. Expanding the Scope of Adenoviral Vectors by Utilizing Novel Tools for Recombination and Vector Rescue
   Julian Fischer et al, 2024, Viruses CrossRef
9. Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells
   Dongxu Kang et al, 2015, Cellular Signalling CrossRef
10. Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells
    Zhezhu Han et al, 2016, Apoptosis CrossRef
11. Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
    Yinghan Su et al, 2022, Journal for ImmunoTherapy of Cancer CrossRef
12. Current landscape and perspective of oncolytic viruses and their combination therapies
    Yinghan Su et al, 2022, Translational Oncology CrossRef
13. High levels of Daxx due to low cellular levels of HSP25 in murine cancer cells result in inefficient adenovirus replication
    Zhezhu Han et al, 2019, Experimental & Molecular Medicine CrossRef
14. A recombinant adenoviral vector with a specific tropism to CD4-positive cells: a new tool for HIV-1 inhibition
    Abtin Behmardi et al, 2022, Drug Delivery and Translational Research CrossRef
15. Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus
    Sujin Kang et al, 2014, Biochemical and Biophysical Research Communications CrossRef
16. A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy
    Ming Yang et al, 2017, Cancer Biology & Therapy CrossRef
17. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
    Zhi Zhu et al, 2022, Molecular Cancer CrossRef